•  
  •  
  •  
  •  

2025-12-29 00:55:52

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • MOU between IITM Pravartak and Methodhub Software Limited
  • Ola Electric scales up deliveries of 4680 Bharat Cell Powered Vehicles
  • MD and CEO of Sigachi Industries Ltd remanded
  • The Monarch Surveyors and Engineering Consultants Ltd receives order worth Rs. 3.29 crore
  • Kotak Mahindra Bank Ltd fixes Jan 14, 2026 as record date for 5:1 stock split

Keywords Selected:  INE203A01020

Stock Report

  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Datopotamab Deruxtecan powder
  • AstraZeneca Pharma India Ltd and Sun Pharma partner to help patients living with Hyperkalaemia in India
  • AstraZeneca Pharma India Ltd to launch Sodium Zirconium Cyclosilicate powder in Nov 2025
  • AstraZeneca Pharma India Ltd receives sale and distribution approval from CDSCO for Trastuzumab Deruxtecan 100mg/5mL vial lyophilized powder
  • AstraZeneca Pharma India Ltd receives permission from CDSCO for Durvalumab Solution
  • AstraZeneca Pharma India Ltd surrenders marketing authorisation for Olaparib 100mg and 150mg
  • AstraZeneca Pharma India Ltd to discontinue the manufacturing and marketing of Imdur from April 1, 2025
  • AstraZeneca Pharma India Ltd receives permission for Olaparib film-coated tablets
  • AstraZeneca Pharma India Ltd to launch Breztri Aerosphere in January 2025 in India
  • AstraZeneca Pharma India Ltd to launch Tremelimumab
  • AstraZeneca Pharma India Ltd to launch Palivizumab in India
  • AstraZeneca Pharma India Ltd updates on exploring contract manufacturer
  • AstraZeneca Pharma India Limited achieves growth of 29% for financial year ended March 31, 2024
  • AstraZeneca Pharma India Ltd and Mankind Pharma partner to accelerate access to asthma medicine for patients in India
  • AstraZeneca Pharma India Ltd receives permission to import new drug
  • AstraZeneca Pharma India Ltd to launch Enhertu in January 2024
  • AstraZeneca Pharma India Ltd receives permission from CDSCO to import new drug
  • AstraZeneca Pharma India Ltd receives permission to Import pharmaceutical formulations of new drug for sale
  • AstraZeneca Pharma India receives permission to import Palivizumab solution for injection
  • AstraZeneca Pharma India Ltd receives permission from DCGI for Dapagliflozin Tablets 10 mg
  • AstraZeneca Pharma India Ltd receives permission for sale and distribution of Trastuzumab deruxtecan
  • AstraZeneca Pharma India receives permission for Dapagliflozin tablets
  • AstraZeneca Pharma India gets permission from DCGI for Olaparib Film-Coated tablets
  • AstraZeneca Pharma India Limited recommends final dividend of Rs. 8

Latest Post

  • MOU between IITM Pravartak and Methodhub Software Limited
  • Ola Electric scales up deliveries of 4680 Bharat Cell Powered Vehicles
  • MD and CEO of Sigachi Industries Ltd remanded
  • The Monarch Surveyors and Engineering Consultants Ltd receives order worth Rs. 3.29 crore
  • Kotak Mahindra Bank Ltd fixes Jan 14, 2026 as record date for 5:1 stock split


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024